Pharmacological treatment of heavy menstrual bleeding varies according to the need for contraception and the presence of haemostatic impairment

Author： Adis International Limited

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.10, 2008-10, pp. : 13-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

By Fraser Ian S.

Drug Safety, Vol. 31, Iss. 4, 2008-01 ,pp. : 275-282

Adis International

Access to resources Recommend Favorite

Tranexamic acid therapy for heavy menstrual bleeding

By Lumsden Mary Ann Wedisinghe Lilantha

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2089-2095

Informa Healthcare

Access to resources Recommend Favorite

UK NICE issues guidance on heavy menstrual bleeding

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The Levonorgestrel-Releasing Intrauterine System in Heavy Menstrual Bleeding: A Benefit-Risk Review

By Kaunitz Andrew M.

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 193-215

Adis International

Access to resources Recommend Favorite

Variceal Bleeding: Pharmacological Treatment and Prophylactic Strategies

By Villanueva Cándid Balanzó Joaquim

Drugs, Vol. 68, Iss. 16, 2008-01 ,pp. : 2303-2324

Adis International

Access to resources Recommend Favorite